查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1975018

全球胰島素輸注裝置市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Insulin Delivery Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計胰島素輸注設備市場將從 2025 年的 194.3 億美元成長到 2034 年的 400.2 億美元，2026 年至 2034 年的複合年成長率為 8.36%。

由於全球糖尿病患者人數不斷增加，以及人們對有效血糖管理的意識提升，全球胰島素輸注設備市場正經歷穩定成長。智慧胰島素筆、穿戴式胰島素幫浦和連網設備等技術創新提高了治療的便利性和患者依從性。人口老化和久坐的生活方式也加劇了對胰島素的需求。醫療機構推廣早期診斷和持續監測，也推動了已開發國家和新興國家對先進胰島素輸注系統的應用。

關鍵成長要素包括微創設備的普及、醫療費用支出的成長以及多個國家有利的報銷政策。持續的產品創新，例如藍牙胰島素筆和整合式血糖監測系統，正在改變糖尿病管理方式。製藥公司正與設備製造商合作，以提高給藥的準確性和安全性。此外，發展中地區醫療基礎設施的不斷完善也為胰島素輸注技術製造商開闢了新的收入來源。

展望未來，數位醫療的融合以及個人化治療方案的進步預計將對市場產生正面影響。人工智慧（AI）和數據分析技術有望提升劑量最佳化和患者追蹤的效率。遠端醫療服務的擴展也加速了遠距糖尿病管理的發展。隨著患者對便利性和便攜性的日益重視，製造商正致力於開發緊湊、自動化且方便用戶使用的系統，預計將推動全球胰島素輸注設備市場的持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球胰島素輸注裝置市場：依產品分類

  • 市場分析、洞察與預測
  • 胰島素筆
  • 胰島素幫浦
  • 胰島素筆針頭
  • 胰島素注射器
  • 其他產品

第5章 全球胰島素輸注裝置市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 居家照護
  • 其他最終用戶

第6章 全球胰島素輸注設備市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly And Company
    • Ypsomed AG
    • Medtronic
    • Insulet Corporation
    • B. Braun SE
    • Owen Mumford Ltd
    • Tandem Diabetes Care Inc
    • BD（Becton Dickinson Company）
簡介目錄
Product Code: VMR112111556

The Insulin Delivery Devices Market size is expected to reach USD 40.02 Billion in 2034 from USD 19.43 Billion (2025) growing at a CAGR of 8.36% during 2026-2034.

The Global Insulin Delivery Devices Market is witnessing steady growth due to the rising prevalence of diabetes worldwide and increasing awareness about effective glucose management. Technological advancements such as smart insulin pens, wearable insulin pumps, and connected devices are improving convenience and patient compliance. Growing geriatric populations and sedentary lifestyles are further contributing to higher insulin demand. Healthcare providers are also promoting early diagnosis and continuous monitoring, which is supporting the adoption of advanced insulin delivery systems across both developed and emerging economies.

Key growth drivers include the shift toward minimally invasive devices, rising healthcare expenditure, and favorable reimbursement policies in several countries. Continuous product innovation, including Bluetooth-enabled pens and integrated glucose monitoring systems, is transforming diabetes management. Pharmaceutical companies are collaborating with device manufacturers to enhance delivery precision and safety. Additionally, expanding healthcare infrastructure in developing regions is opening new revenue streams for manufacturers of insulin delivery technologies.

Looking ahead, the market is expected to benefit from increasing digital health integration and personalized treatment approaches. Artificial intelligence and data analytics will likely enhance dose optimization and patient tracking. Expanding telemedicine services are also encouraging remote diabetes management. With growing patient preference for convenient and portable devices, manufacturers are expected to focus on compact, automated, and user-friendly systems, ensuring sustained long-term growth in the global insulin delivery devices market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Insulin Pens
  • Insulin Pumps
  • Insulin Pen Needles
  • Insulin Syringes
  • Other Products

By End Use

  • Hospitals & Clinics
  • Homecare
  • Other End Users

COMPANIES PROFILED

  • Novo Nordisk AS, Sanofi, Eli Lilly and Company, Ypsomed AG, Medtronic, Insulet Corporation, B Braun SE, Owen Mumford Ltd, Tandem Diabetes Care Inc, BD Becton Dickinson Company
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INSULIN DELIVERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Insulin Pens Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Insulin Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Insulin Pen Needles Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Insulin Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INSULIN DELIVERY DEVICES MARKET: BY END USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INSULIN DELIVERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INSULIN DELIVERY DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Novo Nordisk A/S
    • 8.2.2 Sanofi
    • 8.2.3 Eli Lilly And Company
    • 8.2.4 Ypsomed AG
    • 8.2.5 Medtronic
    • 8.2.6 Insulet Corporation
    • 8.2.7 B. Braun SE
    • 8.2.8 Owen Mumford Ltd
    • 8.2.9 Tandem Diabetes Care Inc
    • 8.2.10 BD (Becton Dickinson Company)